China approves Junshi’s Tuoyi, first domestic anti-PD-1 mAb

China's National Medical Products Administration (NMPA) conditionally approved on Dec. 17 the first domestic anti-PD-1 mAb, Tuoyi toripalimab (JS001)

Read the full 192 word article

User Sign In